Shaw M A, Atkinson S, Dockrell H, Hussain R, Lins-Lainson Z, Shaw J, Ramos F, Silveira F, Mehdi S Q, Kaukab F
Department of Medicine, University of Cambridge Clinical School, UK.
Ann Hum Genet. 1993 Oct;57(4):251-71. doi: 10.1111/j.1469-1809.1993.tb00899.x.
The mycobacterial diseases leprosy and tuberculosis (TB) and the leishmaniases are characterized by a wide spectrum of disease phenotypes, and by the fact that the majority of individuals exposed to the causative organisms Mycobacterium leprae, M. tuberculosis and Leishmania sp. become infected but do not present with clinical disease. In order to determine whether a human homologue to the murine macrophage resistance gene Lsh/Ity/Bcg influences susceptibility to human disease, multicase families for all three diseases have been collected, and linkage analysis performed using a panel of markers in the region of human chromosome 2q33-q37 known to be conserved with the Lsh/Ity/Bcg-containing region of murine chromosome 1. Because of the paucity of available polymorphic markers/linkage information for 2q33-q37, data from 35 multicase leprosy, TB and visceral leishmaniasis families (310 individuals) were first pooled to produce a detailed RFLP map of the region. Peak LOD scores well in excess of 3 were observed for linkage between adjacent pairs of a more proximal (2q33-q35) set of markers CRYGP1, MAP2, FN1, TNP1, VIL1 and DES, and between adjacent pairs of a more distal (2q35-q37) set COL6A3, D2S55 and D2S3. These peak LOD scores and the corresponding values for theta were used in the MAP92 program to generate a multiple two-point map with gene order/map intervals (cM) of: CRYGP1-4.65-MAP2-3.45-FN1-5.95-TNP1-3.41-VIL1-3. 01- DES-20.14-COL6A-10.91-D2S55-3.67-D2S3. Although local support for the placement of loci in this order was weak (LOD < 2, except for DES-COL6A3 where LOD = 6.02), the map is consistent with the gene order for those loci (Cryg, Fn-1, Tp-1, Vil, Des, Col6a3) previously mapped in the mouse. Data from 17 multicase leprosy families (149 individuals) were further analysed for linkage between a putative disease susceptibility locus (DSL) controlling susceptibility to leprosy per se and each of the marker loci. Assuming 100% penetrance for the susceptibility allele, no positive LOD score was obtained for linkage between the DSL and any of the marker genes. Instead, the data provide convincing evidence (LOD scores < -2) that a DSL does not fall within 10-20 cM of CRYGP1, MAP2, TNP1, VIL1, DES or D2S55, or within 5-10 cM of FN1, COL6A3 or D2S3. This effectively excludes a putative DSL controlling susceptibility to leprosy per se from the entire region 2q33-q37.(ABSTRACT TRUNCATED AT 400 WORDS)
分枝杆菌病(麻风病和结核病)以及利什曼病具有多种疾病表型,且大多数接触致病生物(麻风分枝杆菌、结核分枝杆菌和利什曼原虫)的个体虽被感染但未出现临床疾病。为了确定人类中与小鼠巨噬细胞抗性基因Lsh/Ity/Bcg同源的基因是否影响人类疾病易感性,已收集了这三种疾病的多个病例家系,并使用一组位于人类2号染色体2q33 - q37区域(已知该区域与小鼠1号染色体上含Lsh/Ity/Bcg的区域保守)的标记进行连锁分析。由于2q33 - q37区域可用的多态性标记/连锁信息匮乏,首先将来自35个麻风病、结核病和内脏利什曼病多病例家系(共310人)的数据合并,以绘制该区域详细的限制性片段长度多态性(RFLP)图谱。在更靠近近端的(2q33 - q35)一组标记CRYGP1、MAP2、FN1、TNP1、VIL1和DES的相邻对之间,以及更靠近远端的(2q35 - q37)一组标记COL6A3、D2S55和D2S3的相邻对之间,观察到峰值连锁对数优势(LOD)得分远超过3。这些峰值LOD得分及相应的θ值被用于MAP92程序,以生成一个多点图谱,基因顺序/图谱间距(厘摩)为:CRYGP1 - 4.65 - MAP2 - 3.45 - FN1 - 5.95 - TNP1 - 3.41 - VIL1 - 3.01 - DES - 20.14 - COL6A - 10.91 - D2S55 - 3.67 - D2S3。尽管该区域中各基因座以此顺序排列的局部支持较弱(LOD < 2,DES - COL6A3除外,其LOD = 6.02),但该图谱与先前在小鼠中定位的那些基因座(Cryg、Fn - 1、Tp - 1、Vil、Des、Col6a3)的基因顺序一致。对来自17个麻风病多病例家系(149人)的数据进一步分析,以确定控制麻风病易感性的假定疾病易感基因座(DSL)与每个标记基因座之间的连锁关系。假设易感等位基因的外显率为100%,DSL与任何标记基因之间均未获得正向LOD得分。相反,数据提供了令人信服的证据(LOD得分 < -2),表明DSL不在CRYGP1、MAP2、TNP1、VIL1、DES或D2S55的10 - 20厘摩范围内,也不在FN1、COL6A3或D2S3的5 - 10厘摩范围内。这实际上将控制麻风病易感性的假定DSL排除在整个2q33 - q37区域之外。(摘要截选至400字)